Lince Labs - Amniofilm
Santiago
About Lince Labs - Amniofilm
Lince Labs - Amniofilm is a biotech company that specializes in ophthalmologic biotechnology. It develops clinically effective biologically active products in order to improve the health of people. The company serves products such as BioTears, an autologous serum which is the best substituent exists tear their similar components currently being 99%, and their pH and osmolality; and Amniofilm, a human amniotic membrane graft, with potent properties of tissue regeneration has been used successfully in ocular reconstructive surgeries, ulcers, wound treatment, among others. Lince Labs – Amniofilm was founded by Rodrigo Andrews in 2012 and is headquartered in Santiago, Region Metropolitana.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $40.0K
- Funding stage: Seed
- Last round: Seed (Aug 2012)
- Website: lincelabs.cl
- Phone: +56 2 2580 2292
Industries & Categories
Biotechnology, Clinical Trials, Medical
Social Profiles
Canonical: https://fsome.com/organization/lince-labs-amniofilm-2335627 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.